abstract |
The invention relates to a compound of formula (I), where R 1 , R 2 , R 7 , m, n, and L 1 are as defined in claim 1 , and to the methods for preparing same, to the pharmaceutical compositions containing same, and to the uses thereof in the treatment of diseases associated with insulin resistance syndrome. |